MECHANISMS OF CARDIAC NATRIURETIC PEPTIDE SYNTHESIS
心脏钠尿肽的合成机制
基本信息
- 批准号:2734907
- 负责人:
- 金额:$ 8.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-07-01 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis atrial natriuretic peptide cell free system cellular pathology genetic regulation genetic transcription genetic translation heart cell heart function heart ventricle laboratory rat myocardial ischemia /hypoxia northern blottings nuclear runoff assay oxygen tension peptide hormone biosynthesis pulmonary hypertension tissue /cell culture
项目摘要
The aim of this research proposal is to study mechanisms that regulate
cardiac natriuretic peptide (NP) synthesis and release in pulmonary
hypertensive states. Hypoxic pulmonary hypertension and cor pulmonale are
major causes of morbidity and mortality in patients with chronic lung
diseases. Evidence is accruing to suggest that atrial natriuretic peptide
(ANP) and possibly brain naturetic peptide (BNP) play significant roles in
mitigating the development of pulmonary hypertension and right ventricular
hypertrophy during chronic hypoxia. Despite these findings, the mechanisms
that regulate NP synthesis and release are not well understood. We plan to
study two factors that are likely to be involved in stimulating cardiac NP
production during chronic hypoxia: myocardial stretch and reduced oxygen
tension. Plasma NP levels, cardiac NP content, and cardiac transcription
and translation of NPs will be measured in hypoxic and non-hypoxic models
of pulmonary hypertension. In addition, the independent effects of hypoxia
and myocardial stretch will be studied in primary cell cultures of rat
cardiocytes using hypoxic cell culture chambers and a mechanical cell
stretcher. Cardiac production of NPs may be an important hormonal
feedback mechanism to protect the right heart from the development of cor
pulmonale. By better defining how this mechanism is regulated, we hope to
further the understanding of the pathophysiology of hypoxic pulmonary
hypertension and provide insight into how NPs might be used to treat
patients with pulmonary hypertension or chronic lung diseases.
这项研究计划的目的是研究调节的机制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES Raymond KLINGER其他文献
JAMES Raymond KLINGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES Raymond KLINGER', 18)}}的其他基金
Natriuretic Peptides in Pulmonary Endothelial Cell Barrier Function
利钠肽在肺内皮细胞屏障功能中的作用
- 批准号:
7856379 - 财政年份:2009
- 资助金额:
$ 8.11万 - 项目类别:
Natriuretic Peptides in Pulmonary Endothelial Cell Barrier Function
利钠肽在肺内皮细胞屏障功能中的作用
- 批准号:
7245243 - 财政年份:2007
- 资助金额:
$ 8.11万 - 项目类别:
Natriuretic Peptides in Pulmonary Endothelial Cell Barrier Function
利钠肽在肺内皮细胞屏障功能中的作用
- 批准号:
7423860 - 财政年份:2007
- 资助金额:
$ 8.11万 - 项目类别:
Natriuretic Peptides in Pulmonary Endothelial Cell Barrier Function
利钠肽在肺内皮细胞屏障功能中的作用
- 批准号:
7809486 - 财政年份:2007
- 资助金额:
$ 8.11万 - 项目类别:
Natriuretic Peptides in Pulmonary Endothelial Cell Barrier Function
利钠肽在肺内皮细胞屏障功能中的作用
- 批准号:
7616686 - 财政年份:2007
- 资助金额:
$ 8.11万 - 项目类别:
MECHANISMS OF CARDIAC NATRIURETIC PEPTIDE SYNTHESIS
心脏钠尿肽的合成机制
- 批准号:
2210267 - 财政年份:1994
- 资助金额:
$ 8.11万 - 项目类别:
MECHANISMS OF CARDIAC NATRIURETIC PEPTIDE SYNTHESIS
心脏钠尿肽的合成机制
- 批准号:
2444965 - 财政年份:1994
- 资助金额:
$ 8.11万 - 项目类别:
MECHANISMS OF CARDIAC NATRIURETIC PEPTIDE SYNTHESIS
心脏钠尿肽的合成机制
- 批准号:
2210266 - 财政年份:1994
- 资助金额:
$ 8.11万 - 项目类别:
MECHANISMS OF CARDIAC NATRIURETIC PEPTIDE SYNTHESIS
心脏钠尿肽的合成机制
- 批准号:
2210265 - 财政年份:1994
- 资助金额:
$ 8.11万 - 项目类别:
相似海外基金
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
心钠素和心脏代谢健康的调节:基因型引导的人类生理学研究
- 批准号:
10627996 - 财政年份:2022
- 资助金额:
$ 8.11万 - 项目类别:
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
心钠素和心脏代谢健康的调节:基因型引导的人类生理学研究
- 批准号:
10419574 - 财政年份:2022
- 资助金额:
$ 8.11万 - 项目类别:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
心房钠尿肽在盐敏感性高血压中的线粒体介导作用和治疗潜力
- 批准号:
10676800 - 财政年份:2020
- 资助金额:
$ 8.11万 - 项目类别:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
心房钠尿肽在盐敏感性高血压中的线粒体介导作用和治疗潜力
- 批准号:
10442162 - 财政年份:2020
- 资助金额:
$ 8.11万 - 项目类别:
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
心房钠尿肽在盐敏感性高血压中的线粒体介导作用和治疗潜力
- 批准号:
10472035 - 财政年份:2020
- 资助金额:
$ 8.11万 - 项目类别:
Mitochondria-Mediated Effects and Therapeutic Potential of Atrial Natriuretic Peptide in Salt-Sensitive Hypertension Diversity Supplement
盐敏感性高血压多样性补充剂中心房钠尿肽的线粒体介导作用和治疗潜力
- 批准号:
10337412 - 财政年份:2020
- 资助金额:
$ 8.11万 - 项目类别:
Development of a high-precision diagnostic method for heart failure utilizing abnormal biosynthesis of beta-atrial natriuretic peptide in the failing heart
利用衰竭心脏中β-心房钠尿肽的异常生物合成开发心力衰竭的高精度诊断方法
- 批准号:
20K08414 - 财政年份:2020
- 资助金额:
$ 8.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Atrial natriuretic peptide induces peroxisome proliferator
心钠素诱导过氧化物酶体增殖
- 批准号:
15K10206 - 财政年份:2015
- 资助金额:
$ 8.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells.
心房钠尿肽可防止癌症通过血管内皮细胞转移。
- 批准号:
26461393 - 财政年份:2014
- 资助金额:
$ 8.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel strategy for heart failure treatment with recombinant atrial natriuretic peptide-induced cardiac progenitor cells
重组心钠素诱导的心脏祖细胞治疗心力衰竭的新策略
- 批准号:
25461069 - 财政年份:2013
- 资助金额:
$ 8.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)